DDIT4-AS1
gene geneOn this page
Also known as RP11-442H21.2
Summary
DDIT4-AS1 (DDIT4 antisense RNA 1, HGNC:52379) is a long non-coding RNA gene on chromosome 10q22.1.
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:52379 |
| Approved symbol | DDIT4-AS1 |
| Name | DDIT4 antisense RNA 1 |
| Location | 10q22.1 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Aliases | RP11-442H21.2 |
| Ensembl gene | ENSG00000269926 |
| Entrez | 110806271 |
| RNAcentral | URS00026A1AB5 — lncRNA, 2326 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 0
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
None — 0 exons
Expression profiles
Bgee: expression breadth ubiquitous, 128 present calls, max score 93.10.
Top tissues by expression
142 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| ventricular zone | UBERON:0003053 | 93.10 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 91.33 | gold quality |
| epithelium of bronchus | UBERON:0002031 | 89.88 | gold quality |
| vermiform appendix | UBERON:0001154 | 89.22 | gold quality |
| islet of Langerhans | UBERON:0000006 | 88.95 | gold quality |
| pancreas | UBERON:0001264 | 86.71 | gold quality |
| tonsil | UBERON:0002372 | 86.63 | gold quality |
| ganglionic eminence | UBERON:0004023 | 84.29 | gold quality |
| body of pancreas | UBERON:0001150 | 84.22 | gold quality |
| gall bladder | UBERON:0002110 | 84.00 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 83.99 | gold quality |
| colonic epithelium | UBERON:0000397 | 83.73 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 83.03 | gold quality |
| granulocyte | CL:0000094 | 82.46 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 81.32 | gold quality |
| lymph node | UBERON:0000029 | 81.27 | gold quality |
| placenta | UBERON:0001987 | 81.16 | gold quality |
| stromal cell of endometrium | CL:0002255 | 81.12 | gold quality |
| cortical plate | UBERON:0005343 | 80.63 | gold quality |
| bone marrow | UBERON:0002371 | 79.29 | gold quality |
| bone marrow cell | CL:0002092 | 79.24 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 79.08 | gold quality |
| liver | UBERON:0002107 | 78.95 | gold quality |
| calcaneal tendon | UBERON:0003701 | 78.27 | gold quality |
| fallopian tube | UBERON:0003889 | 78.24 | gold quality |
| adrenal tissue | UBERON:0018303 | 78.04 | gold quality |
| rectum | UBERON:0001052 | 77.36 | gold quality |
| apex of heart | UBERON:0002098 | 77.14 | gold quality |
| prefrontal cortex | UBERON:0000451 | 76.85 | gold quality |
| leukocyte | CL:0000738 | 76.83 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 1)
- The m(6)A demethylase ALKBH5-mediated upregulation of DDIT4-AS1 maintains pancreatic cancer stemness and suppresses chemosensitivity by activating the mTOR pathway. (PMID:36056355)
Cross-species orthologs
0 orthologs
Protein
Protein identifiers
Canonical reviewed UniProt: None (reviewed: )
All UniProt accessions (0):
RefSeq proteins (0): (*=MANE)
Domains & families (InterPro)
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 1 (showing top):
chr10q22
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
0 interactions, top by confidence (×1000):
IntAct
0 interactions, top by confidence:
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
129 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 10:72274417:GGAAG:G | donor_gain | 1.0000 |
| 10:72274418:G:GT | donor_gain | 1.0000 |
| 10:72274419:A:T | donor_gain | 1.0000 |
| 10:72274420:AGG:A | donor_loss | 1.0000 |
| 10:72274421:GGTGA:G | donor_loss | 1.0000 |
| 10:72274423:T:G | donor_loss | 1.0000 |
| 10:72274680:T:TA | acceptor_gain | 1.0000 |
| 10:72274690:TCCAG:T | acceptor_loss | 1.0000 |
| 10:72274691:CCA:C | acceptor_loss | 1.0000 |
| 10:72274692:CAG:C | acceptor_loss | 1.0000 |
| 10:72274693:A:AG | acceptor_gain | 1.0000 |
| 10:72274693:A:T | acceptor_loss | 1.0000 |
| 10:72274694:G:A | acceptor_loss | 1.0000 |
| 10:72274694:G:GA | acceptor_gain | 1.0000 |
| 10:72274694:GA:G | acceptor_gain | 1.0000 |
| 10:72274694:GAC:G | acceptor_gain | 1.0000 |
| 10:72274694:GACA:G | acceptor_gain | 1.0000 |
| 10:72274694:GACAC:G | acceptor_gain | 1.0000 |
| 10:72274155:A:AG | acceptor_gain | 0.9900 |
| 10:72274155:AGC:A | acceptor_gain | 0.9900 |
| 10:72274156:G:GG | acceptor_gain | 0.9900 |
| 10:72274156:GC:G | acceptor_gain | 0.9900 |
| 10:72274156:GCG:G | acceptor_gain | 0.9900 |
| 10:72274422:G:GG | donor_gain | 0.9900 |
| 10:72274678:T:TA | acceptor_gain | 0.9900 |
| 10:72274057:GCTG:G | donor_gain | 0.9800 |
| 10:72274155:AGCG:A | acceptor_gain | 0.9800 |
| 10:72274156:GCGG:G | acceptor_gain | 0.9800 |
| 10:72274156:GCGGC:G | acceptor_gain | 0.9800 |
| 10:72274418:GAAG:G | donor_gain | 0.9800 |
AlphaMissense
0 scored. Top likely-pathogenic:
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 0 entries
CTD chemical–gene interactions
7 total (human), top 7 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | decreases expression | 1 |
| dimethylselenide | decreases expression, increases oxidation, increases expression | 1 |
| S-(1,2-dichlorovinyl)cysteine | affects response to substance, increases expression | 1 |
| Lipopolysaccharides | increases expression, affects response to substance | 1 |
| Ozone | decreases expression, increases oxidation | 1 |
| Reactive Oxygen Species | increases expression, decreases expression, increases oxidation | 1 |
| Hydroxyl Radical | decreases expression, increases oxidation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.